Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH study

Version 1 : Received: 13 May 2021 / Approved: 14 May 2021 / Online: 14 May 2021 (14:49:21 CEST)

A peer-reviewed article of this Preprint also exists.

Jones, L.K.; Walters, N.; Brangan, A.; Ahmed, C.D.; Gatusky, M.; Campbell-Salome, G.; Ladd, I.G.; Sheldon, A.; Gidding, S.S.; McGowan, M.P.; Rahm, A.K.; Sturm, A.C. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study. J. Pers. Med. 2021, 11, 587. Jones, L.K.; Walters, N.; Brangan, A.; Ahmed, C.D.; Gatusky, M.; Campbell-Salome, G.; Ladd, I.G.; Sheldon, A.; Gidding, S.S.; McGowan, M.P.; Rahm, A.K.; Sturm, A.C. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study. J. Pers. Med. 2021, 11, 587.

Journal reference: J. Pers. Med. 2021, 11, 587
DOI: 10.3390/jpm11060587

Abstract

Guided by the Conceptual Model of Implementation Research, we explored the acceptability, appropriateness, and feasibility of: 1) automated screening approaches utilizing existing health data to identify those who require subsequent diagnostic evaluation for familial hypercholesterolemia (FH) and 2) family communication methods including chatbots and direct contact to communicate information about inherited risk for FH. Focus groups were conducted with 22 individuals with FH (2 groups) and 20 clinicians (3 groups). These were recorded, transcribed, and analyzed using deductive (coded to implementation outcomes) and inductive (themes based on focus group discussions) methods. All stakeholders described these initiatives as: 1) acceptable and appropriate to identify individuals with FH and communicate risk with at-risk relatives; and 2) feasible to implement in current practice. Stakeholders cited current initiatives, outside of FH (e.g., pneumonia protocols, colon cancer and breast cancer screenings), that gave them confidence for successful implementation. Stakeholders described perceived obstacles, such as nonfamiliarity with FH, that could hinder implementation and potential solutions to improve systematic uptake of these initiatives. Automated health data screening, chatbots, and direct contact approaches may be useful for patients and clinicians to improve FH diagnosis and cascade screening.

Keywords

Familial hypercholesterolemia; identification; implementation outcomes; cascade screening; cascade testing; chatbots; direct contact

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.